The University of Chicago Header Logo

Connection

Arlene Chapman to Time-to-Treatment

Back to Details
This is a "connection" page, showing publications Arlene Chapman has written about Time-to-Treatment.
Arlene Chapman
Connection Strength
0.146
Time-to-Treatment
  1. Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial. Nephrol Dial Transplant. 2018 03 01; 33(3):477-489.
    View in: PubMed
    Score: 0.146
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.